TITLE

Statin Use in Patients with Abnormal Liver Function

PUB. DATE
February 2011
SOURCE
Travel Medicine Advisor;Feb2011 Supplement, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers updates related to pharmacology. According to a study, statins help improve liver abnormalities in patients who have fatty liver and is safe to use. A study suggests that the best time of taking thyroxine is during bedtime. The U.S. Food and Drug Administration (FDA) has removed the breast cancer indication for bevacizumab because of the drug's failure to provide survival benefit for breast cancer patients.
ACCESSION #
58109806

 

Related Articles

  • Statins and liver function. Elliott, William T. // Infectious Disease Alert;Feb2011 Clinical Bri, Vol. 15 Issue 2, p1 

    The article reports on a study published in the "Lancet" which found that statins are safe and may enhance liver abnormalities in patients suffering from fatty liver.

  • Statins and Parkinson's disease.  // Neurology Alert;Sep2013 Pharmacology Watch, p1 

    The article discusses the possibility that continuous medication of statins may lower the risk of Parkinson's disease (PD) and other neurologic disorders. Based on a recent study, patients who continued using liphophilic statins Simvastatin and Atorvastatin showed lower incident rate of PD...

  • Gender Differences with Anticoagulation Discontinuation.  // Travel Medicine Advisor;Oct2008, Vol. 18 Issue 10, p1 

    The article presents an update related to pharmacology as of October 2008. A study by Canadian researchers suggests that women with minimal risk factors may safely stop anticoagulation after six months of therapy, although this does not apply to men. The U.S. Food and Drug Administration (FDA)...

  • Statins: Is There an Increased Risk of Diabetes? Kolich, Meghan N.; Howard, Patricia A. // Hospital Pharmacy;Jul2012, Vol. 47 Issue 7, p513 

    The article discusses the benefits of Statins, the most widely used drug class for the management of dyslipidemia. A study conducted using data from the Women's Health Initiative (WHI) and evaluated the potential for increased risk of diabetes with Statin use in postmenopausal women. The US Food...

  • AVADO: Bevacizumab plus docetaxel met primary endpoint for advanced breast cancer.  // Hem/Onc Today;2/25/2008, Vol. 9 Issue 3, p1 

    The article focuses on a press release announcing the phase-3 AVADO results which states that progression-free survival improved with combination bevacizumab and docetaxel therapy in previously untreated patients with recurrent or metastatic HER2-negative breast cancer. The announcement was made...

  • FDA Approves First New Anti-Obesity Drug in Years.  // Neurology Alert;Aug2012, Vol. 30 Issue 12, p1 

    This section presents updates related to pharmacology. The U.S. Food and Drug Administration (FDA) approved the use of lorcaserin for chronic weight management. The drug will be marketed by Arena Pharmaceuticals as Belviq. A study conducted by the University of California San Diego found that...

  • Statins and Memory Loss.  // Total Health;Jan/Feb2006, Vol. 27 Issue 6, p39 

    This article focuses on several published reports regarding the association of memory loss with the use of cholesterol-lowering statin drugs. In the October 2005 issue of the Canadian Adverse Reactions Newsletter, several cases of memory loss associated with the use of statin drugs were...

  • GUIDANCE ROUND-UP.  // Pulse;3/14/2012, Vol. 72 Issue 9, p13 

    The article offers information related to health including the notice issued by the U.S. Food and Drug Administration regarding the interaction of statins and HIV drugs which can increase the risk of myopathy, updated statin labels ordered by the U.S. Food and Drug Administration for liver...

  • "High-5" for statins; assurance of safety, efficacy.  // Medical Marketing & Media;Oct2001, Vol. 36 Issue 10, p19 

    Reports the efficacy of statins drugs in prolonging lives and preventing heart disease in the U.S. Authority of the usage from the U.S. Food and Drug Administration; Therapeutic contents of satins; Other benefits derived from the product.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics